LCI Industries (NYSE: LCII) has reported earnings for its third fiscal quarter (ending September 30) of $1.02 versus $2.41 for the same period a year ago — a decline of -58%. This result fell short […]
For its first fiscal quarter (ending September 30), Coty Inc (NYSE: COTY) has reported a -100% decline in E.P.S. from $0.15 a year ago to $0.00 in the current quarter. This performance was $-0.17 short […]
CrossAmerica Partners LP (NYSE: CAPL) has reported E.P.S. of $0.31 for its third fiscal quarter (ending September 30) versus $0.71 for the same period a year ago — a decline of -56%. Relative to the […]
The Carlyle Group Inc (NASDAQ: CG) has reported earnings for its third fiscal quarter (ending September 30) of $0.23 versus $0.77 for the same period a year ago — a decline of -70%. This result […]
Assured Guaranty Ltd (NYSE: AGO) has reported earnings for its third fiscal quarter (ending September 30) of $2.65 versus $0.18 for the same period a year ago — an increase of 1372%. This result exceeded […]
On 11/7/23, ADTRAN Holdings Inc (NASDAQ: ADTN) stock suffered a major decline of -26.5%, closing at $5.39. Relative to the market the stock has been extremely weak over the last nine months and has declined […]
Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) stock closed at $4.20 on 11/7/23 after a major decline of -16.7%. Relative to the market the stock has been exceptionally strong over the last nine months but has declined […]
AKAMAI TECHNOLOGIES INC (NASDAQ: AKAM) has reported earnings for its third fiscal quarter (ending September 30) of $1.06 versus $0.78 for the same period a year ago — an increase of 36%. However, this result […]
Riot Platforms Inc (NASDAQ: RIOT) has reported a loss for its third fiscal quarter (ending September 30) of $-0.25 versus a loss $-0.24 for the same period a year ago. Relative to the consensus estimate […]
Fennec Pharmaceuticals Inc (NASDAQ: FENC) has reported E.P.S. of $-0.07 for its third fiscal quarter (ending September 30) versus $-0.31 for the same period a year ago. Relative to the consensus estimate of $-0.12, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research